China NMPA Inspection - Gippercol Group - August 13, 2024

The National Medical Products Administration (NMPA) recently conducted an unannounced inspection of Jipokelai Group, also identified as Geepercare Group. The inspection results, announced on August 13, 2024, revealed that the company failed to comply with key regulatory standards governing cosmetic products. Specifically, Jipokelai Group was found to be in violation of relevant provisions within the "Cosmetics Supervision and Management Regulations" and the "Cosmetics Production and Operation Supervision and Management Measures". While the detailed nature of these violations is not provided in this announcement, the NMPA's findings indicate serious concerns regarding the company's adherence to established safety and operational protocols for cosmetic manufacturing and distribution. In response to these findings, the NMPA has mandated immediate corrective actions. The Zhejiang Provincial Drug Administration has been instructed to direct Jipokelai Group to rectify all identified deficiencies. Furthermore, the NMPA requires that if any suspected illegal activities or further violations are uncovered during the rectification process or subsequent investigation, the Zhejiang Provincial Drug Administration must initiate legal proceedings in accordance with applicable laws. This measure underscores the NMPA's commitment to ensuring public safety in the use of cosmetic products by enforcing strict compliance with national regulations.